Was There an "Early Russian Liberalism"? Perspectives from Russian and Anglo-American Historiography

Authors: Shneider, Konstantin, Fisher, David C

Source: Kritika: Explorations in Russian and Eurasian History. 7(4):825-841

Availability: https://muse.jhu.edu/article/205156

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma

Authors: Looka, Andrew ¹, Qualls, David A. ^{1, ∗}, Matthews, Daniel ¹, Redd, Robert A. ², Sakellis, Christopher ³, Duffy, Caitlyn ¹, Dela Cruz, Jamie ¹, Saucier, Anna ¹, Armand, Philippe ¹, Crombie, Jennifer L. ¹, Fisher, David C. ¹, Jacobsen, Eric D. ¹, Kim, Austin I. ¹, LaCasce, Ann S. ¹, Merryman, Reid W. ¹, Parry, Erin M. ¹, Jacobson, Caron A. ¹

Source: In Blood Advances 11 February 2025 9(3):455-462

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Authors: Ahn, Inhye E., Brander, Danielle M., Ren, Yue, Zhou, Yinglu, Tyekucheva, Svitlana, Walker, Heather A., Black, Robert, Montegaard, Josie, Alencar, Alvaro, Shune, Leyla, Omaira, Mohammad, Jacobson, Caron A., Armand, Philippe, Ng, Samuel Y., Crombie, Jennifer, Fisher, David C., LaCasce, Ann S., Arnason, Jon, Hochberg, Ephraim P., Takvorian, Ronald W., Abramson, Jeremy S., Brown, Jennifer R., Davids, Matthew S.

Source: In Blood Advances 27 February 2024 8(4):832-841

Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

Authors: Merryman, Reid W., Redd, Robert A., Taranto, Eleanor, Ahmed, Gulrayz, Jeter, Erin, McHugh, Kristin M., Brown, Jennifer R., Crombie, Jennifer L., Davids, Matthew S., Fisher, David C., Freedman, Arnold S., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Ng, Samuel Y., Odejide, Oreofe O., Parry, Erin M., Jacene, Heather, Park, Hyesun, Dahi, Parastoo B., Nieto, Yago, Joyce, Robin M., Chen, Yi-Bin, Shipp, Margaret A., Herrera, Alex F., Armand, Philippe

Source: In Blood Advances 12 September 2023 7(17):4748-4759

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Authors: Merrill, Mwanasha H., Dahi, Parastoo B., Redd, Robert A., McDonough, Mikaela M., Chen, Yi-Bin, DeFilipp, Zachariah, Herrera, Alex F., Fisher, David C., LaCasce, Ann S., Odejide, Oreofe O., Ng, Samuel Y., Jacobson, Caron A., Merryman, Reid W., Kim, Austin I., Nieto, Yago L., Sauter, Craig S., Shah, Gunjan L., Zain, Jasmine M., Armand, Philippe, Jacobsen, Eric D.

Source: In Blood 17 August 2023 142(7):621-628

Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis

Authors: Gooptu, Mahasweta, Kim, Haesook T., Jacobsen, Eric, Fisher, David C., LaCasce, Ann, Ho, Vincent T., Cutler, Corey S., Koreth, John, Soiffer, Robert J., Antin, Joseph H., Berliner, Nancy, Nikiforow, Sarah

Source: In Blood Advances 13 June 2023 7(11):2309-2316

Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome

Authors: Davids, Matthew S., Rogers, Kerry A., Tyekucheva, Svitlana, Wang, Zixu, Pazienza, Samantha, Renner, Sarah K., Montegaard, Josie, Ihuoma, Udochukwu, Lehmberg, Timothy Z., Parry, Erin M., Wu, Catherine J., Jacobson, Caron A., Fisher, David C., Thompson, Philip A., Brown, Jennifer R.

Source: Blood. 139(5):686-689

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183249541.0x000001&indx=1&recIds=ETOCvdc_100183249541.0x000001

Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review

Authors: Plumptre, Isabella R., Said, Jordan T., Sun, Tiffany, Larocca, Cecilia, Virgen, Cesar A., Kupper, Thomas S., Fisher, David C., Devlin, Philip M., Elco, Christopher P., Song, Johanna Sheu, LeBoeuf, Nicole R.

Source: Leukemia & lymphoma. 63(12):2832-2846

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100174774074.0x000001&indx=1&recIds=ETOCvdc_100174774074.0x000001

Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation

Authors: Taranto, Eleanor, Redd, Robert, Jeter, Erin, McHugh, Kristin, Crombie, Jennifer L., Fisher, David C., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Odejide, Oreofe O., Dahi, Parastoo B., Nieto, Yago, Joyce, Robin M., Chen, Yi-Bin, Bonjoc, Kimberley-Jane C., Chaudhry, Ammar, Herrera, Alex F., Armand, Philippe, Merryman, Reid W.

Source: Leukemia & lymphoma. 63(12):2912-2917

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173039611.0x000001&indx=1&recIds=ETOCvdc_100173039611.0x000001

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

Authors: Davids, Matthew S., Ryan, Christine E., Lampson, Benjamin L., Ren, Yue, Tyekucheva, Svitlana, Fernandes, Stacey M., Crombie, Jennifer L., Kim, Austin I., Weinstock, Matthew, Montegaard, Josie, Walker, Heather A., Greenman, Claire, Patterson, Victoria, Jacobson, Caron A., LaCasce, Ann S., Armand, Philippe, Fisher, David C., Lo, Steve, Olszewski, Adam J., Arnason, Jon E.

Source: Journal of Clinical Oncology; 3/1/2025, Vol. 43 Issue 7, p788-799, 21p

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data

Authors: Horwitz, Steven M. ^*, Scarisbrick, Julia J., Dummer, Reinhard, Whittaker, Sean, Duvic, Madeleine, Kim, Youn H., Quaglino, Pietro, Zinzani, Pier Luigi, Bechter, Oliver, Eradat, Herbert, Pinter-Brown, Lauren, Akilov, Oleg E., Geskin, Larisa, Sanches, Jose A., Ortiz-Romero, Pablo L., Weichenthal, Michael, Fisher, David C., Walewski, Jan, Trotman, Judith, Taylor, Kerry, Dalle, Stephane, Stadler, Rudolf, Lisano, Julie, Bunn, Veronica, Little, Meredith, Prince, H. Miles

Source: In Blood Advances 14 December 2021 5(23):5098-5106

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

Authors: Davids, Matthew S ^*, Lampson, Benjamin L, Tyekucheva, Svitlana, Wang, Zixu, Lowney, Jessica C, Pazienza, Samantha, Montegaard, Josie, Patterson, Victoria, Weinstock, Matthew, Crombie, Jennifer L, Ng, Samuel Y, Kim, Austin I, Jacobson, Caron A, LaCasce, Ann S, Armand, Philippe, Arnason, Jon E, Fisher, David C, Brown, Jennifer R

Source: In The Lancet Oncology October 2021 22(10):1391-1402

Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma

Authors: Martz, Colin A., Jarbeau, Jennifer F., Castillo, Jorge J., Fisher, David C., Nohria, Anju

Source: In JACC: CardioOncology June 2021 3(2):326-329

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

Authors: Brown, Jennifer R., Walker, Sarah R., Heppler, Lisa N., Tyekucheva, Svitlana, Nelson, Erik A., Klitgaard, Josephine, Nicolais, Maria, Kroll, Yasmin, Xiang, Michael, Yeh, Jennifer E., Chaudhury, Mousumi, Giaccone, Zachary T., Fernandes, Stacey M., Jacobsen, Eric D., Fisher, David C., Freedman, Arnold S., Davids, Matthew S., Supko, Jeffrey G., Wu, Catherine, Frank, David A.

Source: American journal of hematology. 96(4):E95-E98

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120766975.0x000001&indx=1&recIds=ETOCvdc_100120766975.0x000001

A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay

Authors: Chase, Matthew L., Merryman, Reid, Fisher, David C., Jacobsen, Eric, LaCasce, Ann, Jacobson, Caron, Freedman, Arnold, Davids, Matthew S., Brown, Jennifer R., Jacob, Allison, Armand, Philippe, Crombie, Jennifer

Source: Leukemia & lymphoma. 62(2):478-481

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114474022.0x000001&indx=1&recIds=ETOCvdc_100114474022.0x000001

A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma.

Authors: Jacobsen, Eric, Plant, Ashley, Redd, Robert, Armand, Philippe, McDonough, Mikaela, Ihuoma, Udochukwu, Fisher, David C., LaCasce, Ann, Ritz, Jerome, Dranoff, Glenn, Freedman, Arnold

Source: Leukemia & Lymphoma; Dec2024, Vol. 65 Issue 12, p1864-1874, 11p

Subject Terms: GRANULOCYTE-macrophage colony-stimulating factor, KILLER cells, FOLLICULAR lymphoma, IMMUNOLOGICAL adjuvants, T cells

Primary cutaneous EBV+ extranodal NK/T‐cell lymphoma of gamma/delta T‐cell lineage in the posttransplantation setting.

Authors: Williams, Jessica F., Lucas, Fabienne M., Carrasco, Ruben D., Lovitch, Scott B., Fisher, David C., Kupper, Thomas S., Sadigh, Sam

Source: Journal of Cutaneous Pathology; Oct2024, Vol. 51 Issue 10, p777-782, 6p

Subject Terms: MYCOSIS fungoides, SEZARY syndrome, SKIN biopsy, LIVER transplantation, LYMPHOMAS, LYMPHOPROLIFERATIVE disorders

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Authors: Frigault, Matthew J. ^*, Armand, Philippe ^*, Redd, Robert A., Jeter, Erin, Merryman, Reid W., Coleman, Kimberly C., Herrera, Alex F., Dahi, Parastoo, Nieto, Yago, LaCasce, Ann S., Fisher, David C., Ng, Samuel Y., Odejide, Oreife O., Freedman, Arnold S., Kim, Austin I., Crombie, Jennifer L., Jacobson, Caron A., Jacobsen, Eric D., Wong, Jeffrey L., Bsat, Jad, Patel, Sanjay S., Ritz, Jerome, Rodig, Scott J., Shipp, Margaret A., Chen, Yi-Bin, Joyce, Robin M.

Source: In Blood Advances 14 January 2020 4(1):122-126

Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial

Authors: Davids, Matthew S ^*, Brander, Danielle M, Kim, Haesook T, Tyekucheva, Svitlana, Bsat, Jad, Savell, Alexandra, Hellman, Jeffrey M, Bazemore, Josie, Francoeur, Karen, Alencar, Alvaro, Shune, Leyla, Omaira, Mohammad, Jacobson, Caron A, Armand, Philippe, Ng, Samuel, Crombie, Jennifer, LaCasce, Ann S, Arnason, Jon, Hochberg, Ephraim P, Takvorian, Ronald W, Abramson, Jeremy S, Fisher, David C, Brown, Jennifer R

Source: In The Lancet Haematology August 2019 6(8):e419-e428

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Authors: Armand, Philippe ^*, Chen, Yi-Bin, Redd, Robert A., Joyce, Robin M., Bsat, Jad, Jeter, Erin, Merryman, Reid W., Coleman, Kimberly C., Dahi, Parastoo B., Nieto, Yago, LaCasce, Ann S., Fisher, David C., Ng, Samuel Y., Odejide, Oreofe O., Freedman, Arnold S., Kim, Austin I., Crombie, Jennifer L., Jacobson, Caron A., Jacobsen, Eric D., Wong, Jeffrey L., Patel, Sanjay S., Ritz, Jerome, Rodig, Scott J., Shipp, Margaret A., Herrera, Alex F.

Source: In Blood 4 July 2019 134(1):22-29